Zelnorm (tegaserod) may come back

Patients are hearing that Zelnorm (tegaserod) may come back.

Zelnorm was pulled from the market last spring after being linked to heart attacks, strokes, and unstable angina.

Now the manufacturer is in talks with Health Canada to bring it back...but only for certain patients.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote